Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil.
Pharmacy Course, Universidade do Vale do Itajaí (UNIVALI), Itajaí, Santa Catarina, Brazil.
J Ethnopharmacol. 2019 May 10;235:248-254. doi: 10.1016/j.jep.2019.02.014. Epub 2019 Feb 12.
Aleurites moluccana is used in folk medicine to treat pain, fever, asthma, hepatitis, gastric ulcer and inflammatory process in general, and the nut oil had been topically applied to treat arthritis and other joint pain, however the seeds are classified as toxic for oral use.
Faced with the need for new alternative to treat the symptoms and modify rheumatoid arthritis (RA) the aim of this work was to evaluate the effects of A. moluccanus' leaves dried extract in rats and mice submitted to complete Freund adjuvant (CFA)-induced RA.
Wistar Rats and Swiss mice were submitted to CFA-induced RA in the right hindpaw. They received A. moluccanus extract (orally; p.o.), dexamethasone (subcutaneously), 2″-O-rhamnosylswertisin (p.o.) or vehicle (p.o.), from the 14th day after the CFA injection for up to 8 days. The mechanical hypersensitivity was evaluated using the von Frey filaments and the paw-oedema was measured using a plethysmometer. The rats' injected hindpaw was used to perform the histological analysis.
A. moluccanus was able to significantly reduce the mechanical hypersensitivity in both ipsi- and contralateral hindpaws of mice injected with CFA, in a dose dependent manner. Furthermore, the paw-oedema was progressively reduced by A. moluccanus. Similar results were obtained for the positive-control drug dexamethasone and the isolated compound 2″-O-rhamnosylswertisin. Besides the effects mentioned above, the extract was also effective to repair the joint damage in CFA-induced RA rats, including reduction of fibrosis, cartilage degradation and bone erosion scores.
These results together with the literature data reinforce the anti-hypersensitivity and anti-inflammatory activity of A. moluccanus extract. Part of the observed effects is due to the presence of the compound 2″-O-rhamnosylswertisin. The fact that the extract acted as a disease modifier point this herbal product as a promisor and safe tool to treat RA and other associated chronic diseases.
乌桕被民间医学用于治疗疼痛、发热、哮喘、肝炎、胃溃疡和一般炎症过程,其果仁油曾被局部用于治疗关节炎和其他关节疼痛,但该种子被归类为有毒,不可口服。
鉴于需要新的替代方法来治疗症状和改善类风湿性关节炎(RA),本工作的目的是评估在完全弗氏佐剂(CFA)诱导的 RA 大鼠和小鼠中乌桕叶干提取物的作用。
Wistar 大鼠和瑞士小鼠的右后爪接受 CFA 诱导的 RA。它们接受乌桕提取物(口服;p.o.)、地塞米松(皮下)、2″-O-鼠李糖基 swertisin(口服)或载体(口服),从 CFA 注射后第 14 天开始,最多持续 8 天。使用 von Frey 纤维评估机械性感觉过敏,使用体积描记仪测量爪肿胀。用注射后腿评估大鼠的组织学分析。
乌桕提取物能够以剂量依赖的方式显著降低 CFA 注射小鼠的同侧和对侧后爪的机械感觉过敏。此外,乌桕提取物逐渐减轻爪肿胀。阳性对照药物地塞米松和分离化合物 2″-O-鼠李糖基 swertisin 也得到了类似的结果。除了上述作用外,该提取物还能有效修复 CFA 诱导的 RA 大鼠的关节损伤,包括减少纤维化、软骨降解和骨侵蚀评分。
这些结果以及文献数据加强了乌桕提取物的抗感觉过敏和抗炎活性。观察到的部分作用归因于 2″-O-鼠李糖基 swertisin 的存在。提取物作为疾病修饰剂的事实表明,该草药产品是治疗 RA 和其他相关慢性疾病的有前途且安全的工具。